Target intelligence / Profile preview

Beta-mammal toxin Cn2 (Cn2)

Target
Cn2
Molecular classification
Scorpion venom toxin, Beta-scorpion toxin, Sodium channel modulator
01

Overview

Beta-mammal toxin Cn2 is a potent neurotoxin derived from the venom of the Mexican scorpion Centruroides noxius, one of the most dangerous scorpion species in the world. It functions as a beta-scorpion toxin that specifically targets voltage-gated sodium (Nav) channels, particularly the Nav1.6 subtype, by shifting their activation threshold to more negative potentials and inducing a subthreshold sodium current. This leads to uncontrolled neuronal firing and systemic neurotoxicity, which can result in respiratory distress and death in mammals. In a therapeutic context, Cn2 is the primary target for neutralizing antivenoms and recombinant antibody fragments (scFvs) designed to treat severe envenomation. Understanding its structure and interaction with sodium channels is critical for the development of more effective, next-generation antivenoms and as a tool in neuropharmacological research.

Other names
Centruroides noxius toxin 2Cn2 toxinBeta-toxin Cn2Sodium channel modifier Cn2
02

Mechanism of action

Neutralization of the toxin by specific antibodies or F(ab')2 fragments to prevent its binding to voltage-gated sodium channels.

03

Biological functions

Voltage-gated sodium channel modulationInduction of subthreshold sodium currentShift of activation voltage to more negative potentialsNeurotoxicity
04

Disease associations

Scorpion envenomationNeurotoxicityRespiratory failure
05

Safety considerations

Anaphylaxis to antivenomSerum sicknessRapid onset of severe neurotoxicity requiring immediate intervention
06

Interacting drugs

Alacramyn (Centruroides antivenom)

2 more in the full profile.

07

Biomarkers

Serum toxin levelsClinical signs of scorpionism (e.g., fasciculations, sialorrhea)

Beyond the preview

Go deeper on Beta-mammal toxin Cn2 (Cn2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-mammal toxin Cn2 (Cn2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call